Evidence map›Paper›PMID 16614412›Full record

ArticleThe Journal of nutrition2006

Skeletal muscle protein anabolic response to increased energy and insulin is preserved in poorly controlled type 2 diabetes.

Jill A Bell, Elena Volpi, Satoshi Fujita, Jerson G Cadenas, Melinda Sheffield-Moore, Blake B Rasmussen

2 registry-linked trialsAbstract read
In one paragraph

Article in The Journal of nutrition, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00690534 phase1completednot on this map

Insulin and Sarcopenia in the Elderly

TypeinterventionalSponsorThe University of Texas Medical Branch, GalvestonRan2005 to 2012Enrolled88ConditionsSarcopeniaArmsInsulin Regular, L-NMMA, Sodium Nitroprusside, mixed meal
NCT00891696 phase1completednot on this mapstarted 2009, after this paper: background citation

Nutritional and Contractile Regulation of Muscle Growth (Cycle 2)

TypeinterventionalSponsorThe University of Texas Medical Branch, GalvestonRan2009 to 2015Enrolled144ConditionsSarcopeniaArmsRapamycin, Amino acid supplementation, Low-intensity resistance exercise, Sodium nitroprusside, Blood flow restriction cuff
3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 51 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Aging · 2023
    Article
  5. Article
  6. Review
  7. Article
  8. Observational
  9. Article
  10. Review
  11. Article
  12. Differential control of muscle mass in type 1 and type 2 diabetes mellitus.Cellular and molecular life sciences : CMLS · 2015
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jill A BellDepartment of Kinesiology, University of Southern California, Los Angeles, CA, USA.
Elena Volpi
Satoshi Fujita
Jerson G Cadenas
Melinda Sheffield-Moore
Blake B Rasmussen
University of Southern California · USThe University of Texas Medical Branch at Galveston · US

Funding

UTMB OAIC Research Education Component (REC)P30AG024832 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI JAMES S. GOODWIN, MD, MELISSA M. MORROW · 2005 to 2026
$26.7M
INSULIN AND SARCOPENIA IN THE ELDERLYR01AG018311 · NIA · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI VOLPI, ELENA · 2000 to 2010
$3.3M
Nutritional and Contractile Regulation of Muscle GrowthR01AR049877 · NIAMS · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI RASMUSSEN, BLAKE B · 2004 to 2012
$3.3M
NCRR NIH HHS M01-RR-43NCRR NIH HHS S10 RR1650NIAMS NIH HHS R01 AR049877NIA NIH HHS P30 AG024832NIA NIH HHS R01 AG018311NIA NIH HHS R01 AG18311
6 · The paper itself

Abstract

Type 2 diabetes (T2DM) subjects failing diet treatment are characterized by hyperinsulinemia and insulin resistance leading to fasting and postprandial hyperglycemia and hyperlipidemia. Energy is essential for allowing the process of protein synthesis to proceed. Additionally, insulin can stimulate protein synthesis in human muscle. The aims of this study were to determine if poorly controlled T2DM affects postabsorptive muscle protein anabolism, and if the muscle anabolic response to hyperinsulinemia with high energy availability is maintained. Control (n = 6) and T2DM subjects (n = 6) were studied in the postabsorptive state and during an isoenergetic high nutritional energy clamp (relative to postabsorptive state). Muscle protein synthesis and breakdown (nmol . min(-1) . 100 g leg muscle(-1)) were assessed using stable isotope methodology, femoral arterio-venous sampling, muscle biopsies, and a three-pool model to calculate protein turnover. Postabsorptive phenylalanine net balance and whole body rate of appearance (Ra) were not different between groups; however, basal muscle protein breakdown was higher in T2DM (94 +/- 9) than in controls (58 +/- 12) (P < 0.05) and muscle protein synthesis tended (P = 0.07) to be elevated in T2DM (66 +/- 14) compared with controls (39 +/- 6). During the clamp, net balance increased, whole body Ra and muscle protein breakdown decreased (P < 0.05), and muscle protein synthesis tended to decrease (P = 0.08) to a similar extent in both groups. We conclude that postabsorptive muscle protein turnover is elevated in poorly controlled T2DM, however, there is no excessive loss of muscle protein because net balance is not different from controls. Moreover, the anabolic response to increased insulin and energy availability is maintained in T2DM.

Indexed as

Energy MetabolismAdipose TissueAdultBody Mass IndexDiabetes Mellitus, Type 2FastingFemaleHumansMaleModels, BiologicalMuscle ProteinsMuscle, SkeletalPostprandial PeriodReference ValuesMuscle Proteins

Identifiers

PMID16614412
PMCPMC3196634
OpenAlexW1920416693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.